Literature DB >> 4211843

Breakdown of pulse-labeled ribonucleic acid and polysomes in Bacillus megaterium: actions of streptolydigin, echinomycin, and triostins.

M Waring, A Makoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4211843

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  12 in total

1.  Kinetic evidence that echinomycin migrates between potential DNA binding sites.

Authors:  K R Fox; M J Waring
Journal:  Nucleic Acids Res       Date:  1985-01-25       Impact factor: 16.971

2.  The binding of echinomycin to deoxyribonucleic acid.

Authors:  S P Wakelin; M J Waring
Journal:  Biochem J       Date:  1976-09-01       Impact factor: 3.857

3.  Binding of quinoline analogues of echinomycin to deoxyribonucleic acid. Role of the chromophores.

Authors:  K R Fox; D Gauvreau; D C Goodwin; M J Waring
Journal:  Biochem J       Date:  1980-12-01       Impact factor: 3.857

4.  Interaction between synthetic analogues of quinoxaline antibiotics and nucleic acids: role of the disulphide cross-bridge and D-amino acid centres in des-N-tetramethyl-triostin A.

Authors:  K R Fox; R K Olsen; M J Waring
Journal:  Br J Pharmacol       Date:  1980-09       Impact factor: 8.739

5.  Echinomycin inhibits chromosomal DNA replication and embryonic development in vertebrates.

Authors:  Laurence G May; Mark A Madine; Michael J Waring
Journal:  Nucleic Acids Res       Date:  2004-01-02       Impact factor: 16.971

6.  Bifunctional intercalation and sequence specificity in the binding of quinomycin and triostin antibiotics to deoxyribonucleic acid.

Authors:  J S Lee; M J Waring
Journal:  Biochem J       Date:  1978-07-01       Impact factor: 3.857

7.  Preparation and DNA-binding properties of substituted triostin antibiotics.

Authors:  A Cornish; K R Fox; M J Waring
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

8.  The use of radiolabelled triostin antibiotics to measure low levels of binding to deoxyribonucleic acid.

Authors:  K R Fox; A Cornish; R C Williams; M J Waring
Journal:  Biochem J       Date:  1983-06-01       Impact factor: 3.857

Review 9.  Echinomycin: the first bifunctional intercalating agent in clinical trials.

Authors:  B J Foster; K Clagett-Carr; D D Shoemaker; M Suffness; J Plowman; L A Trissel; C K Grieshaber; B Leyland-Jones
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

10.  Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancer.

Authors:  S Wadler; L Tenteromano; L Cazenave; J A Sparano; E S Greenwald; A Rozenblit; R Kaleya; P H Wiernik
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.